CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue:
Total revenue	$ 943,630	$ 860,546	$ 1,843,825	$ 1,697,095
Cost of Revenue:
Cost of revenue	370,780	346,514	728,004	684,310
Gross profit	572,850	514,032	1,115,821	1,012,785
Expenses:
Sales and marketing	140,532	130,257	288,336	262,549
General and administrative	89,669	81,488	159,770	159,437
Research and development	46,505	123,221	91,172	163,389
Income from operations	296,144	179,066	576,543	427,410
Interest expense	(10,542)	(8,317)	(23,669)	(15,313)
Interest income	327	334	743	477
Income before provision for income taxes	285,929	171,083	553,617	412,574
Provision for income taxes	61,693	39,104	115,327	86,630
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 224,236	$ 131,979	$ 438,290	$ 325,944
Earnings per Share:
Basic (in USD per share)	$ 2.70	$ 1.57	$ 5.28	$ 3.87
Diluted (in USD per share)	$ 2.67	$ 1.56	$ 5.22	$ 3.82
Weighted Average Shares Outstanding:
Basic (in shares)	83,086	83,922	83,039	84,164
Diluted (in shares)	83,983	84,858	83,980	85,222
Product revenue
Revenue:
Total revenue	$ 540,680	$ 492,518	$ 1,046,622	$ 970,895
Cost of Revenue:
Cost of revenue	179,999	167,323	353,609	329,394
Service revenue
Revenue:
Total revenue	402,950	368,028	797,203	726,200
Cost of Revenue:
Cost of revenue	$ 190,781	$ 179,191	$ 374,395	$ 354,916